Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Degoul, F.
Right arrow Articles by Florentz, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Degoul, F.
Right arrow Articles by Florentz, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 7, 347-354, Copyright © 1998 by Oxford University Press

ARTICLES

Isoleucylation properties of native human mitochondrial tRNAIle and tRNAIle transcripts. Implications for cardiomyopathy-related point mutations (4269, 4317) in the tRNAIle gene

F Degoul, H Brule, C Cepanec, M Helm, C Marsac, J Leroux, R Giege and C Florentz
INSERM U75, Faculte de Medecine Necker-Enfants Malades, 156 rue de Vaugirard, 75730 Paris Cedex 15, France.

A growing number of mutated mitochondrial tRNA genes have been found associated with severe human diseases. To investigate the potential interference of such mutations with the primordial function of tRNAs, i.e. their aminoacylation by cognate aminoacyl-tRNA synthetases, a human mitochondrial in vitro aminoacylation system specific for isoleucine has been established. Both native tRNAIleand isoleucyl-tRNA synthetase activity have been recovered from human placental mitochondria and the kinetic parameters of tRNA aminoacylation determined. The effect of pathological point mutations present in the mitochondrial gene encoding tRNAIlehas been tackled by investigating the isoleucylation properties of wild-type and mutated in vitro transcripts. Data show that: (i) modified nucleotides contribute to efficient isoleucylation; (ii) point mutation A4269G in the gene (A-->G at nt 7 in the tRNA), associated with a cardiomyopathy, does not affect aminoacylation significantly; (iii) point mutation A4317G (A-->G at nt 59 in the tRNA), reported in a case of fatal infantile cardiomyopathy, induces a small but significant decrease in isoleucylation. The potential implications of these findings on the understanding of the molecular mechanisms involved in the expression of pathology are discussed.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Ling, H. Roy, D. Qin, M. A. T. Rubio, J. D. Alfonzo, K. Fredrick, and M. Ibba
Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome
PNAS, September 25, 2007; 104(39): 15299 - 15304.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
L. Levinger, M. Morl, and C. Florentz
Mitochondrial tRNA 3' end metabolism and human disease
Nucleic Acids Res., October 11, 2004; 32(18): 5430 - 5441.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
M. SISSLER, M. HELM, M. FRUGIER, R. GIEGE, and C. FLORENTZ
Aminoacylation properties of pathology-related human mitochondrial tRNALys variants
RNA, May 1, 2004; 10(5): 841 - 853.
[Abstract] [Full Text] [PDF]

Home page
 GENES CELLSHome page
N. Hino, T. Suzuki, T. Yasukawa, K. Seio, K. Watanabe, and T. Ueda
The pathogenic A4269G mutation in human mitochondrial tRNAIle alters the T-stem structure and decreases the binding affinity for elongation factor Tu
Genes Cells, March 1, 2004; 9(3): 243 - 252.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Tomari, N. Hino, T. Nagaike, T. Suzuki, and T. Ueda
Decreased CCA-addition in Human Mitochondrial tRNAs Bearing a Pathogenic A4317G or A10044G Mutation
J. Biol. Chem., May 2, 2003; 278(19): 16828 - 16833.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
L. Levinger, R. Giege, and C. Florentz
Pathology-related substitutions in human mitochondrial tRNAIle reduce precursor 3' end processing efficiency in vitro
Nucleic Acids Res., April 1, 2003; 31(7): 1904 - 1912.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
L. M. Wittenhagen, M. D. Roy, and S. O. Kelley
The pathogenic U3271C human mitochondrial tRNALeu(UUR) mutation disrupts a fragile anticodon stem
Nucleic Acids Res., January 15, 2003; 31(2): 596 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
M. Dorner, M. Altmann, S. Paabo, and M. Morl
Evidence for Import of a Lysyl-tRNA into Marsupial Mitochondria
Mol. Biol. Cell, September 1, 2001; 12(9): 2688 - 2698.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
T. Yasukawa, N. Hino, T. Suzuki, K. Watanabe, T. Ueda, and S. Ohta
A pathogenic point mutation reduces stability of mitochondrial mutant tRNAIle
Nucleic Acids Res., October 1, 2000; 28(19): 3779 - 3784.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. Arenas, Y. Campos, B. Bornstein, R. Ribacoba, M. A. Martin, J. C. Rubio, F. M. Santorelli, M. Zeviani, S. DiMauro, and R. Garesse
A double mutation (A8296G and G8363A) in the mitochondrial DNA tRNALys gene associated with myoclonus epilepsy with ragged-red fibers
Neurology, January 1, 1999; 52(2): 377 - 377.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
S. O. Kelley, S. V. Steinberg, and P. Schimmel
Fragile T-stem in Disease-associated Human Mitochondrial tRNA Sensitizes Structure to Local and Distant Mutations
J. Biol. Chem., March 30, 2001; 276(14): 10607 - 10611.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.